RIMA M SALIBA to Topotecan
This is a "connection" page, showing publications RIMA M SALIBA has written about Topotecan.
Connection Strength
0.039
-
Phase II trial of high-dose topotecan, melphalan and CY with autologous stem cell support for multiple myeloma. Bone Marrow Transplant. 2011 Apr; 46(4):510-5.
Score: 0.021
-
Symptom burden after autologous stem cell transplantation for multiple myeloma. Cancer. 2008 Apr 01; 112(7):1617-24.
Score: 0.018